(1)
Pivadga, C.; Odum, E. P.; Hart, B. A. A.-. Hydroxyurea Dose Escalation to Maximum Tolerated Dose in Pediatric Sickle Cell Disease: Hematologic and Clinical Outcomes in a Resource-Limited Setting in Cameroon. A Quasi-Experimental Study. SJHR-Africa 2026, 7 (3), 10. https://doi.org/10.51168/6zd3jy11.